Pfizer (PFE) Prepaid Assets (2009 - 2026)

Pfizer (PFE) has reported Prepaid Assets for 16 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Prepaid Assets rose 30.93% year-over-year to $3.5 billion in Q2 2026; TTM through Jun 2026 was $3.5 billion, a 30.93% increase from a year earlier, with the FY2025 full-year figure at $2.8 billion, down 33.98% from the prior year.
• Prepaid Assets was $3.5 billion for Q2 2026 at Pfizer, up from $2.9 billion in the prior quarter.
• Over five years, Prepaid Assets peaked at $6.0 billion in Q3 2022 and troughed at $2.4 billion in Q3 2025.
• A 5-year average of $4.0 billion and a median of $4.2 billion in 2022 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets jumped 56.36% in 2022 and plunged 38.83% in 2025, its largest moves.
• Over 5 years, Prepaid Assets stood at $5.0 billion in 2022, then decreased by 2.11% to $4.9 billion in 2023, then declined by 13.4% to $4.3 billion in 2024, then plunged by 33.98% to $2.8 billion in 2025, then advanced by 25.43% to $3.5 billion in 2026.
• The last three Prepaid Assets figures came in at $3.5 billion (Q2 2026), $2.9 billion (Q1 2026), and $2.8 billion (Q4 2025), per Business Quant data.